iHEAR® Medical announced today the launch of the Free @Home iHEARtest™ campaign, offering consumers the ability to test their hearing for free at home

iHEAR Medical, Inc., the leader in direct-to-consumer hearing solutions, announced today a nationwide expansion into 2,500 drugstore locations, following a

iHEAR Medical announced today the launch of the next generation iHEARhd, the first home-programmable invisible hearing aid for mild to moderate hearing losses.

With iHEAR's patented technology, consumers will be able to subscribe to advanced hearing aids and optional wireless services on a pay-as-you-go model or at a low monthly fee.

San Leandro, CA, November 12, 2018 --(PR.com)-- Hearing loss and diabetes are two of America’s most widespread health concerns, both on the rise. Nearly 48 million American adults have disabling hearing loss, according to the Center for Hearing and Communication, and more than 30 million adults in the U.S. have diabetes.

iHEAR® Medical is giving consumers control of their own hearing health with the first ever Food and Drug Administration-cleared home-hearing assessment kit, called the iHEARtest™, a clinical paradigm shift in effective, affordable and accessible hearing screening technology.

What’s your hearing number?™ National chain and independent drug stores across the country will be stocking their shelves with the innovative iHEARtest™ so consumers can bring the kit home, take the 5 - 6 minute assessment and learn what their Hearing Number™ is on a scale from 1 to 5 (from profound hearing loss to good hearing in each ear).

Industry veteran John Luna appointed CEO to lead commercialization of iHEAR's advanced hearing solutions to wider markets

SAN LEANDRO, Calif., March 20, 2018 -- iHEAR Medical, the leader in direct-to-consumer and OTC hearing solutions, announced today that it has partnered with Atlazo Inc. to develop an advanced digital hardware platform to power iHEAR's next generation of hearing aids and hearables.

SAN LEANDRO, Calif., Jan. 31, 2018 /-- iHear Medical, the leader in direct-to-consumer hearing aid solutions, announced today that it has partnered with FSAstore.com to offer the iHearTest,

iHear Medical offers a wide range of innovative hearing products and services, including the only FDA-cleared OTC home hearing test, advanced customized hearing aids for discreet wear, and remote professional support by licensed hearing professionals to serve local communities anywhere with online access.

SAN LEANDRO, Calif., June 26, 2017 /PRNewswire/ -- iHEAR Medical announces the launch of Eva™, the first hearing aid designed specifically to address hearing loss of women. Over 20 million women in the U.S.,

SAN LEANDRO, Calif., June 5, 2017 -- iHEAR Medical supports the Over-the-Counter (OTC) Hearing Aid Act of 2017, which was recently introduced in Congress to improve access and affordability of hearing aids.

The problem is not, for the most part, the hardware, which can be cheap. Rather, associated costs like research and development and a lifetime of servicing get folded into the price. Also, only about a half-dozen companies

SAN LEANDRO, Calif., Jan. 19, 2017 -- iHear Medical, Inc. announced today the closing of $4.1 million in Series C-2 financing. The round was led by Ameritas, iHEAR's partner for marketing and distribution of advanced web-enabled hearing aids.

The partnership with Ameritas offers next generation invisible hearing solutions at a fraction of the cost. This groundbreaking offering is intended to break through persisting barriers preventing people from obtaining clinically effective hearing solutions

. iHEAR's products include the iHEARHD and iHEARMAX invisible hearing aids, and the iHEARTEST, the first and only FDA-cleared home hearing screener.

iHear's patented fitting system and method optimize the consumer's hearing experience in challenging situations, such as discerning soft female speech and listening in noisy conditions.

Announced today that it has signed an agreement with Flex (NASDAQ: FLEX), whereby Flex will serve as the Company's primary manufacturer and supplier as iHear Medical prepares to transition to mass production.

The cloud-based platform developed by iHear Medical encompasses numerous first-of-a-kind innovations to empower consumers and break through persisting barriers preventing people from obtaining clinically effective hearing solutions.

We are excited to welcome Dr. Daniel Hartman as a director and a scientific advisor to the company,” said Adnan Shennib, founder and CEO of iHear Medical.

iHear Medical announced today that it has received FDA clearance for the iHearTest™, the world's first hearing screener approved for over-the-counter (OTC) sales.

The distribution agreement with AIER was announced by Adnan Shennib, President and CEO of iHear Medical, at the China Medtech Partnering (CMP-2015) Conference in Suzhou, China.

.The participants in this round included Brother Industries (Japan) and Ameritas Holding Company. The C-round was led earlier by Lighthouse Capital

iHear Medical announced today the completion of its third round of financing totaling $2.5M to enable iHear Medical complete the development and launch

The iHEAR HD will be sold for $199, making it much more affordable than conventional devices that often cost thousands of dollars.

The campaign offers a free hearing device to an economically disadvantaged individual for every hearing

iHear Medical announced today its plans to introduce the world’s first web-enabled hearing aid system, targeting tech-savvy

iHear®Medical announces the completion of its second round of financing totaling $1.8M. The new funding will enable the company

Consumers today are offered a dizzying array of hearing aid options ranging from full-featured behind-the-ear (BTE) products to “invisible” and completely-in-the-canal (CIC) hearing aids which offer cosmetic appeal.